Access Pharmaceuticals, Inc.
American Stock Exchange accepts pharma firm's plan for compliance
Published in Pharma Investments, Ventures and Law Weekly, August 7th, 2005
In April 2005, the company received notice from the AMEX Staff indicating that the company is below certain of AMEX's continued listing standards:
1) due to losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million, as set forth in Section 1003(a)(i) of the AMEX "Company Guide";
2) due to losses from continuing operations and/or net losses in 3 of its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Adventrx Pharmaceuticals, Inc.
Pharmaceutical company joins the new Russell Microcap index - Alpharma, Inc.
Pharma company declares regular quarterly cash dividend - Avesthagen
Indian biotech firm among key investors in U.K. - Azee, Inc.
Genomics company completes agreement for small molecule technology - Bausch & Lomb
Ophthalmology firm to acquire Chinese ophthalmic pharmaceuticals company - Bavarian Nordic A/S
U.S. patent granted for modified virus ankara - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
